# Meropenem

## Mepem inj 0.25gm

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IMEP2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 適應症     | Bacterial meningitis: Treatment of bacterial meningitis in pediatric patients 3 months and older caused by Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis Complicated skin and skin structure infections: Treatment of complicated skin and skin structure infections in adults and pediatric patients 3 months and older caused by Staphylococcus aureus (methicillin-susceptible isolates only), Streptococcus pyogenes, S. agalactiae, viridans group streptococci, Enterococcus faecalis (vancomycin-susceptible isolates only), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis, and Peptostreptococcus species Intra-abdominal infections: Treatment of complicated appendicitis and peritonitis in adult and pediatric patients caused by viridans group streptococci, E. coli, Klebsiella pneumoniae, P. aeruginosa, B. fragilis, B. thetaiotaomicron, and Peptostreptococcus species Canadian labeling: Additional indications (not in U.S. labeling): Treatment of lower respiratory tract infections (community-acquired and nosocomial pneumonias), uncomplicated skin and skin structure infections, complicated urinary tract infections, gynecologic infections (excluding chlamydia), and septicemia; treatment of bacterial meningitis in adults caused by S. pneumoniae, H. influenzae, and N. meningitidis (use in adult meningitis based on pediatric data) |
| 用法用量   | Adults: 0.5-2 g in 2-3 divided doses IV infused over 30 minutes. Children: 30-120 mg/kg in 2-3 divided doses IV infused over 30 minutes (max. 2 g/day). *****NEONATE ANTIBIOTICS DOSE***** Meropenem: general infection Body weight <1kg ge<=7day 20mg/kg Q12H  Age 8-14 day 20mg/kg Q12H  Age 15-28 day 20 mg/kg Q8H Body weight 1-2kg ge<=7day 20mg/kg Q12H  Age 8-14 day 20 mg/kg Q8H  Age 15-28 day 20 mg/kg Q8H Body weight >2kg Age<=7day 20 mg/kg Q8H  Age 8-14 day 30 mg/kg Q8H  Age 15-28 day 30mg/kg Q8H meningitis Body weight <1kg ge<=7day 40mg/kg Q12H  Age 8-14 day 40mg/kg Q12H  Age 15-28 day 40 mg/kg Q8H Body weight 1-2kg ge<=7day 40mg/kg Q12H  Age 8-14 day 40 mg/kg Q8H  Age 15-28 day 40 mg/kg Q8H Body weight >2kg Age <=7ayd 40 mg/kg Q8H  Age 8-14 d ay 40 mg/kg Q8H  Age 15-28 day 40mg/kg Q8H                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌       | Hypersensitivity to meropenem, other drugs in the same class, or any component of the formulation; patients who have experienced anaphylactic reactions to beta-lactams                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 副作用     | Shock, serious renal disorders including acute renal failure, serious colitis accompanied with bloody stool, pseudomembranous colitis, interstitial pneumonia & PIE syndrome. CNS convulsion e.g. seizures, consciousness disorders. Lyell syndrome, Steven-Johnson syndrome, pancytopenia, agranulocytosis, leucopenia, hepatic disorders, jaundice, rash, urticaria, feeling of warmth, erythema, pruritus, fever & redness. Granulocytopenia, eosinophilia, thrombocytopenia or thrombocytosis & lymphocytosis increased GOT/GPT/LDH/A1-P/LAP/γ-GTP/bilirubin/urinary urobilinogen, decreased cholinesterase, increased urinary β2-microglobulin/BUN/creatinine, abdominal pain, diarrhea, nausea, vomiting & anorexia, stomatitis, candidiasis, vit K deficiency symptoms, vit B complex deficiency symptoms, headache, malaise. Dermatologic: Injection site inflammation (2.4% ) Gastrointestinal: Constipation (1.4% to 7% ), Diarrhea (3.5% to 7% ), Nausea and vomiting (3.6% adults; 0.8% children ) Neurologic: Headache (2.3% to 7.8% )                                                                                                                                                                                                                                                                                                                                                                                             |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

